Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Division of Ophthalmic Devices consolidating contact lens branches.

This article was originally published in The Gray Sheet

Executive Summary

FDA'S OPHTHALMIC DEVICES DIVISION CONSOLIDATING CONTACT LENS BRANCHES under a pilot reorganization of the division to be imple-mented Sept. 5. The two branches will be combined and renamed the "Vitreal and Extraocular Devices Branch," reflecting the addition of devices such as tamponades, gases and silicone gels to the branch's purview. These devices currently are reviewed by DOD's Surgical and Diagnostic Devices Branch.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT004549

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel